Tag Archives: Antibody

Eli Lilly CEO’s pay grows—again—to $23.7M after COVID antibody launch, new approvals

The COVID-19 pandemic derailed plans for companies worldwide last year, but Eli Lilly adapted by developing medicines against the novel coronavirus—to the tune of $ 871 million in antibody revenue for Q4—while still pushing sales of its newer meds. Now, CEO David Ricks is reaping the rewards with a pay package that could place him… Read More »

FDA Approves Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) Antibody Cocktail for Ebola (Zaire Ebolavirus)

TARRYTOWN, N.Y., Oct. 14, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the U.S. Food and Drug Administration (FDA) approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including newborns of mothers who have tested positive for the infection. “We are… Read More »

All about monoclonal antibody drugs — the experimental treatment that may have turned Trump’s COVID-19 around

Article content continued “It’s entirely possible that by the time you’re giving it, you’re giving it too late.” Medical technicians work at a drive-through COVID-19 testing facility at the Regeneron Pharmaceuticals company’s Westchester campus in Tarrytown, New York, September 17, 2020. Photo by Brendan McDermid/Reuters/File That Trump got something wholly experimental has raised eyebrows, but… Read More »

DBI antibody, N-term – diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein), 50 μg supplied

Rabbit Polyclonal antibody to DBI. This gene encodes diazepam binding inhibitor, a protein that is regulated by hormones and is involved in lipid metabolism and the displacement of beta-carbolines and benzodiazepines, which modulate signal transduction at type A gamma-aminobutyric acid receptors located in brain synapses. The protein is conserved from yeast to mammals, with the… Read More »